Cargando…

Nebulised heparin for patients on ventilation: implications for COVID-19 pneumonia

Detalles Bibliográficos
Autores principales:	Ball, Lorenzo, Schultz, Marcus J, Pelosi, Paolo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2021
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7826131/ https://www.ncbi.nlm.nih.gov/pubmed/33493452 http://dx.doi.org/10.1016/S2213-2600(20)30513-0

Ejemplares similares

Nebulised interferon beta-1a for patients with COVID-19
por: Peiffer-Smadja, Nathan, et al.
Publicado: (2021)

Battling COVID-19-related mortality: from a fight for ventilators to a cry for oxygen
por: Schultz, Marcus J, et al.
Publicado: (2021)

Nebulised heparin as a treatment for COVID-19: scientific rationale and a call for randomised evidence
por: van Haren, Frank M. P., et al.
Publicado: (2020)

A phase 1 trial of nebulised heparin in acute lung injury
por: Dixon, Barry, et al.
Publicado: (2008)

Nebulised heparin: a new approach to the treatment of acute lung injury?
por: Suter, Peter M
Publicado: (2008)

Sedation in mechanically ventilated patients with COVID-19
por: Page, Valerie
Publicado: (2021)

Inhaled nebulised unfractionated heparin (UFH) for the treatment of hospitalised patients with COVID-19: A randomised controlled pilot study()
por: DeNucci, Gilberto, et al.
Publicado: (2023)

How I ventilate an obese patient
por: Ball, Lorenzo, et al.
Publicado: (2019)

Authors` response to “Efficacy of noninvasive ventilation in patients with COVID-19”
por: Polok, Kamil, et al.
Publicado: (2022)

Are height and weight estimates in ED patients reliable for setting the ventilator?
por: Hemmes, Sabrine N.T., et al.
Publicado: (2017)

Delivering evidence-based critical care for mechanically ventilated patients with COVID-19
por: Salluh, Jorge I F, et al.
Publicado: (2020)

Walking the line between benefit and harm from tracheostomy in COVID-19
por: Schultz, Marcus J, et al.
Publicado: (2020)

Nebuliser Type Influences Both Patient-Derived Bioaerosol Emissions and Ventilation Parameters during Mechanical Ventilation
por: Joyce, Mary, et al.
Publicado: (2021)

COVID-19 pneumonia and the appropriate use of antibiotics
por: Ginsburg, Amy Sarah, et al.
Publicado: (2020)

COVID-19-related acute respiratory distress syndrome: lessons learned during the pandemic
por: Schultz, Marcus J, et al.
Publicado: (2022)

A glass half-full: defining ventilator-associated pneumonia in the neonatal intensive care unit
por: Whitesel, Emily D., et al.
Publicado: (2020)

Can nebulised HepArin Reduce morTality and time to Extubation in patients with COVID‐19 Requiring invasive ventilation Meta‐Trial (CHARTER‐MT): Protocol and statistical analysis plan for an investigator‐initiated international meta‐trial of prospective randomised clinical studies
por: van Haren, Frank M. P., et al.
Publicado: (2022)

Implications of COVID-19 for patients with pre-existing digestive diseases
por: Mao, Ren, et al.
Publicado: (2020)

Complement C5a inhibition: a new form of COVID-19 treatment for mechanically ventilated patients?
por: Kalil, Andre C, et al.
Publicado: (2022)

COVID-19 interstitial pneumonia: monitoring the clinical course in survivors
por: Raghu, Ganesh, et al.
Publicado: (2020)

COVID-19 pneumonia: what has CT taught us?
por: Lee, Elaine Y P, et al.
Publicado: (2020)

Implications of COVID-19 for patients with pre-existing digestive diseases: an update
por: Mao, Ren, et al.
Publicado: (2021)

Implications of COVID-19 for uveitis patients: perspectives from Hong Kong
por: Hung, Jennifer C. H., et al.
Publicado: (2020)

COVID-19: immunopathology and its implications for therapy
por: Cao, Xuetao
Publicado: (2020)

Nebulised Isotonic Hydroxychloroquine Aerosols for Potential Treatment of COVID-19
por: Tai, Waiting, et al.
Publicado: (2021)

COPD: Will There Be Room for Nebulisers After the Current COVID-19 Pandemic?
por: Araújo, António Duarte de, et al.
Publicado: (2020)

Implications of COVID-19 sequelae for health-care personnel
por: Praschan, Nathan, et al.
Publicado: (2021)

COVID-19: implications for immunosuppression in kidney disease and transplantation
por: Kronbichler, Andreas, et al.
Publicado: (2020)

Leveraging the COVID-19 response to end preventable child deaths from pneumonia
por: Fore, Henrietta H, et al.
Publicado: (2020)

Zanamivir should be inhaled, not nebulised
por: Eagel, Barry A
Publicado: (2010)

Double Nebulisation for Airway Anaesthesia
por: Chugh, Vanya, et al.
Publicado: (2020)

COVID-19 and endoscopy: implications for healthcare and digestive cancer screening
por: Gralnek, Ian M., et al.
Publicado: (2020)

The type I interferon response in COVID-19: implications for treatment
por: Lee, Jeong Seok, et al.
Publicado: (2020)

Implications of COVID-19 vaccine effectiveness waning for public health
por: Odone, Anna, et al.
Publicado: (2022)

The lapse of federal COVID-19 funding: implications for health equity
por: Kobayashi, Kelsen, et al.
Publicado: (2023)

Severe breakthrough COVID-19 infections in Scotland—implications for immunisation programmes
por: Leshem, Eyal, et al.
Publicado: (2021)

COVID-19 and systemic sclerosis: clinicopathological implications from Italian nationwide survey study
por: Ferri, Clodoveo, et al.
Publicado: (2021)

Microbial contamination of domiciliary nebulisers and clinical implications in chronic obstructive pulmonary disease
por: Jarvis, S, et al.
Publicado: (2014)

Nebulised heparin for patients with or at risk of acute respiratory distress syndrome: a multicentre, randomised, double-blind, placebo-controlled phase 3 trial
por: Dixon, Barry, et al.
Publicado: (2021)

Genomics in the era of COVID-19: ethical implications for clinical practice and public health
por: Geller, Gail, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8b8mmq5a4jgu95vuklbc2cbobq